Novel Medication Tied to Better QoL in Major Depression
An investigational, 2-week oral neuroactive steroid improved measures of function and quality of life to near-normal levels in patients with major depression, new research shows. Medscape Medical News
An investigational, 2-week oral neuroactive steroid improved measures of function and quality of life to near-normal levels in patients with major depression, new research shows. Medscape Medical News